- Demographic variables, exposures, and clinical characteristics of children with COVID-19 (N=62).
| Demographics | n (%) |
|---|---|
| Age, years | 6 (0.2-13) |
| Gender | |
| Male | 31(50) |
| Female | 31 (50) |
| Nationality | |
| Saudi | 37 (59.7) |
| Yemeni | 9 (14.5) |
| Indian | 5 (8.1) |
| Others | 11 (17.7) |
| Exposures | |
| History of contact with COVID-19 positive patient | 48 (77.4) |
| COVID-19 positive family member | 41 (66.1) |
| COVID-19 positive patient outside family | 7 (11.3) |
| Unknown exposure | 14 (22.6) |
| Parents are health care providers | 4 (6.5) |
| Clinical manifestations | |
| History of fever | 50 (80.6) |
| Documented fever in hospital | 17 (27.4) |
| Fever category (°C) | |
| 37.7-38 | 8 (12.90) |
| >38-39 | 8 (12.90) |
| >39 | 1 (1.61) |
| Fever duration, days | 2 (1-9) |
| Respiratory symptoms | |
| Cough | 30 (48.4) |
| Runny nose | 17 (27.4) |
| Sore throat | 11 (17.7) |
| Shortness of breath | 8 (12.9) |
| Anosmia | 1 (1.6) |
| General non-specific symptoms | |
| Headache | 6 (9.7) |
| Body aches | 3 (4.8) |
| Myalgia | 5 (8.1) |
| Gastrointestinal symptoms | |
| Diarrhea | 15 (24.2) |
| Vomiting | 11 (17.7) |
| Abdominal pain | 6 (9.7) |
| Skin rash | 1 (1.6) |
| Seizures | 3 (4.8) |
| Associated comorbidities | 9 (14.5) |
| Congenital heart disease | 3 (4.8) |
| Bronchial asthma/adenoid/bronchiolitis obliterans | 3 (4.8) |
| Malignancy (rhabdomyosarcoma) | 1 (1.6) |
| Hydrocephalous (brain atrophy) | 2 (3.2) |
Values are presented as numbers and percentages (%).